Joseph Gagnon Jr., CRNP, PMHNP-BC
He / Him
Sr Psychiatric-Mental Health Nurse Practitioner
“
What sets this practice apart from others is the amount of time and detail we put into our evaluations and follow-up sessions with our clients. We look at the full-picture and tailor treatment to each clients’ specific needs. At PIP we also focus on educating ourselves on the latest research findings and best practice approaches in psychiatry in order to provide the highest possible level of care for our clients.
“
-
Joe specializes in the treatment of ADHD (including in children, teens, adults, older adults, and adult-onset ADHD), Autism Spectrum Disorder, Anxiety Disorders (including OCD), Depression, Movement Disorders (specifically Tardive Dyskinesia and Akathisia), Psychotic Disorders (including early onset Schizophrenia and Schizoaffective Disorder), Bipolar Disorder, and Addictive Disorders (Substance Abuse, Binge Eating Disorder, and Gambling Use Disorder). He has extensive experience in treating both children and adolescents. Additionally, he holds a waiver for completion of specialized training in the use of Medications for Addiction Treatment (MAT) for assisting individuals struggling with Substance Use Disorders. Joe is our Senior Psychiatric Nurse Practitioner and he provides weekly supervision sessions with each of our other nurse practitioners.
Joe has nearly two decades of psychiatric experience including inpatient, outpatient, and emergency crisis response center settings. His psychiatric work experience includes positions at Lehigh Valley Health Network, The Horsham Clinic, The University of Pennsylvania Health System (Pennsylvania Hospital and Penn Presbyterian Medical Center), Thomas Jefferson University Health System, Haven Behavioral Hospital of Eastern Pennsylvania, Berkshire Psychiatric, and Penn Psychiatric Center.
In addition to his role as an outpatient psychiatric provider, Joe also has experience presenting nationwide to other prescribers regarding the treatment and diagnosis of Tardive Dyskinesia, Attention-Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Bipolar Depression. Joe maintains active adjunct faculty status in the Department of Nursing at Montgomery County Community College where he teaches undergraduate nursing students in both the clinical and classroom setting. Additionally, he has served as a clinical faculty instructor for graduate and doctorate level students at Anderson University, Chamberlain University, Drexel University, Eastern Kentucky University, Herzig University, La Salle University, Liberty University, Maryville University, Montgomery County Community College, Post University, Rocky Mountain University, Spring Arbor University, University of Cincinnati, Walden University, and Wilkes University for students studying to become Psychiatric-Mental Health Nurse Practitioners.
Joe graduated Summa Cum Laude from Walden University with a Master of Science in Nursing and he is board-certified as a Psychiatric-Mental Health Nurse Practitioner to treat across the lifespan by the American Nurses Credentialing Center (ANCC). He is also board-certified by the ANCC as a Psychiatric Registered Nurse. Joe is licensed as a Psychiatric Nurse Practitioner in both PA and NJ. He also has supplemental education in Plant-Based Medicine through Cornell University.
-
Cornell University, Certificate in Medicinal Plants
Walden University, Master of Science in Nursing (MSN)
DeSales University: Bachelor of Science in Nursing (BSN)
West Chester University of Pennsylvania: Bachelor of Science in Professional Studies, Minors in Biology, Nutrition and Psychology
-
Psychiatric-Mental Health Nurse Practitioner (Across the Lifespan) (PMHNP-BC) Board-Certification by the ANCC
Psychiatric-Mental Health Registered Nurse (RN-BC) Board Certification by the ANCC
Medications for Addiction Treatment Waiver Certification
Psychiatric-Mental Health Nurse Practitioner License in PA and NJ
Drug Enforcement Administration (DEA) License in PA and NJ
Controlled Dangerous Substance License in NJ
-
English
some French
-
17
Joseph Gagnon Jr. specializes in
treating these conditions
by providing these services
Read the latest from Joseph Gagnon Jr.:
Alcohol use disorder (AUD) presents a significant challenge in the realm of addiction treatment, yet there is a growing list of promising pharmacological agents. Among these, Naltrexone stands out as a well-tolerated medication that has shown significant promise in reducing alcohol consumption.
Our practice specializes in treating patients with holistic approaches that recognize the significant benefits of incorporating dietary and nutritional strategies into mental health care.
We specialize in complex differential diagnoses and understand that accurately identifying conditions like schizophrenia takes time and expertise.
Metformin, a medication traditionally used to manage type 2 diabetes, has been a cornerstone of treatment for over six decades. However, recent research has unveiled its potential beyond glucose regulation, suggesting that metformin may play a significant role in anti-aging and the prevention of age-related diseases.
Buspirone offers a safer alternative for treating anxiety with a lower risk of abuse and dependence. It's important for patients to work closely with their healthcare provider to find the most effective dose and to monitor for side effects or interactions with other medications.
Zoloft, known generically as sertraline, is a selective serotonin reuptake inhibitor SSRI commonly prescribed to treat a variety of mental health disorders. It works by increasing the amount of serotonin, a natural substance in the brain that helps with various mental health disorders.
The recent Mood Treatment with Antidepressants or Running, or MOTAR study, published in the Journal of Affective Disorders and led by Brenda Penninx, has provided valuable insights into the connection between exercise and mental health, particularly highlighting running therapy's efficacy in treating depression and anxiety disorders.
Catatonia is a complex psychomotor syndrome, often arising from various mental health disorders such as bipolar disorder, schizophrenia, autism, and major depressive disorder.
In the realm of mental health, innovative treatments are constantly being explored to offer hope and relief to those suffering from various conditions.
When starting a new antidepressant, patients often wonder how they can enhance the medication's effectiveness and improve their overall mental health.
Viibryd (vilazodone) is an FDA-approved medication for treating major depressive disorder (MDD) in adults, known for its faster action compared to many other antidepressants.
In the realm of holistic mental health care, the ancient herb Ashwagandha (Withania somnifera) has emerged as a beacon of hope for individuals grappling with anxiety and insomnia.
Philadelphia Integrative Psychiatry stands at the forefront of treating Restless Legs Syndrome (RLS), a condition many of our patients face.
For our patients at Philadelphia Integrative Psychiatry, this information is invaluable when considering treatment options.
ADHD stimulant medications are widely used for their effectiveness in managing symptoms of Attention Deficit Hyperactivity Disorder (ADHD).
Sleep problems are a common challenge in children with ASD, affecting their quality of life significantly. These disturbances can stem from various factors, including emotional dysregulation and sensory processing issues.
Serotonin syndrome is a potentially life-threatening condition that occurs when there is an excess of serotonin due to medication combinations or drug use.
Inositol, a naturally occurring substance found in various forms in the body and foods, has shown promising results in the management of Obsessive-Compulsive Disorder (OCD).
At Philadelphia Integrative Psychiatry, we pride ourselves on being at the forefront of the latest research to provide our patients with the most informed and comprehensive care possible.
We integrate mindfulness, CBT, and chronotherapy alongside medication for comprehensive ADHD care. Embracing non-pharmacologic interventions is key in our approach to all disorders.
At Philadelphia Integrative Psychiatry, we are deeply committed to providing comprehensive and personalized psychiatric care that views each patient as a whole person, not just a diagnosis.
In our continuous effort to stay abreast of the latest research and developments in psychiatric care, we delve into the significant role of lithium in treating bipolar disorder, a topic of paramount importance to our practice.
Selective serotonin reuptake inhibitors (SSRIs) are the mainstay medications for anxiety, but other options should be considered due to potential side effects.
A recent study highlights how Quetiapine, even at low doses, can have significant antidepressant effects.
Psychological treatments are preferred as a first-line approach, but prescribing rates of SSRIs have risen due to various factors.
The use of two antipsychotic meds together, can be more effective than one, especially in complex cases.
Our discussion provides a comprehensive look at the importance of understanding sensory processing challenges.
Iron deficiency is a widespread nutritional concern with profound implications for human health.